SCHEMBL8567131

SCHEMBL8567131

Cc1ccc(C(F)Cl)c(F)c1F

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10544542 0.81 HTT (0.33) HPGD
SCHEMBL22183998 0.79 HPGD (0.32) HPGD
SCHEMBL2258516 0.77 HPGD (0.34) HPGD
SCHEMBL5089366 0.77 HPGD (0.31) HPGD
SCHEMBL10779530 0.76 CES2 (0.42)
SCHEMBL9100028 0.76 LMNA (0.37) HPGD
SCHEMBL2993973 0.76
SCHEMBL28707291 0.74 USP2 (0.32) HPGD
SCHEMBL15375841 0.74
SCHEMBL30064 0.74 ACHE (0.42) HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0866793-A4 1998-10-07 EP disclosed
EP-0866793-A1 NITROIMIDAZOLE ANTIBACTERIAL COMPOUNDS AND METHODS OF USE THEREOF PATHOGENESIS CORPORATION (US) 1998-09-30 EP disclosed
WO-1997001562-A1 NITROIMIDAZOLE ANTIBACTERIAL COMPOUNDS AND METHODS OF USE THEREOF PATHOGENESIS CORPORATION (US) 1997-01-16 WO disclosed